Articles Tagged With:
-
Shorter Length of Stay if ED Workup Completed Before Surgical Consult
Researchers reported completion of workups, such as basic labs and imaging before consultation, resulted in patients spending less time in the ED. Average consultant-to-decision time was 2.5 hours for patients with complete workups vs. 4.9 hours for those with incomplete workups.
-
Hospitalist Triage Role Expedites Admission Decisions for ED Patients
This intervention alone likely will not reduce the number of boarded patients. But with accurate data in hand, the focus can shift to alleviating the downstream bottlenecks that prevent patients from going to inpatient beds sooner.
-
Many Patients Avoid Going to EDs Because of Fear of Boarding, Delays
Emergency physicians should convey to patients that they will receive care, regardless of the boarding crisis. Stick to the foundation of emergency medical care: stabilize, ensure patients are not experiencing a life-threatening emergency, and manage their urgent conditions.
-
Calling ED Boarding a Public Health Crisis, ACEP Pushes Policymakers to Act
Although there are many possible solutions, both legislative and administrative, the industry continues searching for the right formula to solve the problem.
-
EMTALA Concerns if Patients Ask About Delays
Are discouraging comments an EMTALA violation? Investigators would examine factors such as what exactly was stated, under what circumstances the comment was made, whether the information was truthful and accurate, and whether it discouraged the patient from staying in the ED and receiving care.
-
Aberrant Conduction?
How should one interpret the ECG in the figure? Is the rhythm most likely to be a re-entry supraventricular tachycardia with aberrant conduction?
-
Momelotinib Tablets (Ojjaara)
Momelotinib can be prescribed to treat intermediate- or high-risk myelofibrosis.
-
Major Cardiovascular Event Risk Reduction with Pitavastatin in Patients Living with HIV
Among participants living with HIV who are at low-to-moderate risk for cardiovascular disease, those who received pitavastatin were 35% less likely to experience a major adverse cardiovascular event over a follow-up of approximately five years vs. those who received placebo.
-
The Hemodynamic Effects of an SGLT2 Inhibitor in Heart Failure with Preserved Ejection Fraction
The authors of a small, placebo-controlled study of 24 weeks of dapagliflozin therapy in patients with heart failure with preserved ejection fraction reported reductions in pulmonary capillary wedge pressure, which may explain the reductions in heart failure hospitalizations or cardiovascular death in larger randomized outcome trials.
-
Biomarker Profiles of Those Living to Age 100 Years
Among 1,224 participants who lived to their 100th birthday, there were higher levels of total cholesterol and iron, and lower levels of glucose, creatinine, uric acid, liver enzymes, and alkaline phosphatase compared with non-centenarians. These differences were seen as early as age 65 years.